2003
DOI: 10.1038/ni944
|View full text |Cite
|
Sign up to set email alerts
|

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

Abstract: During activation, T cells express receptors for receiving positive and negative costimulatory signals. Here we identify the B and T lymphocyte attenuator (BTLA), an immunoglobulin domain-containing glycoprotein with two immunoreceptor tyrosine-based inhibitory motifs. BTLA is not expressed by naive T cells, but it is induced during activation and remains expressed on T helper type 1 (T(H)1) but not T(H)2 cells. Crosslinking BTLA with antigen receptors induces its tyrosine phosphorylation and association with … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

25
908
3
7

Year Published

2005
2005
2024
2024

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 766 publications
(964 citation statements)
references
References 50 publications
25
908
3
7
Order By: Relevance
“…Soon after, a manuscript reporting a mouse knockout of the same gene with an immune response phenotype was submitted by another group that had discovered the gene independently. 71 IRIS genes can also be used as cell markers in the analysis of microarray experiments. For example, tumor vs normal tissue analysis may benefit from recognition of genes involved in the immune response as opposed to carcinogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…Soon after, a manuscript reporting a mouse knockout of the same gene with an immune response phenotype was submitted by another group that had discovered the gene independently. 71 IRIS genes can also be used as cell markers in the analysis of microarray experiments. For example, tumor vs normal tissue analysis may benefit from recognition of genes involved in the immune response as opposed to carcinogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…B- and T-lymphocyte attenuator (BTLA) is another co-inhibitory receptor whose expression is induced during activation of T cells, leading to inhibition of human CD8 + cancer-specific T cells. 12 Like PD-1 and CTLA-4, BTLA interacts with a B7 homolog, B7H4, but unlike PD-1 and CTLA-4, BTLA displays T cell inhibition via interaction with tumor necrosis family receptors (TNF-R), not just the B7 family of cell surface receptors.…”
Section: Introductionmentioning
confidence: 99%
“…Additionally, SHP-2 can be co-precipitated with the inhibitory coreceptor CTLA-4 (CD152) and CD3-f, which has led to the hypothesis that SHP-2 mediates inhibitory signals from CTLA-4 [22][23][24][25]. Furthermore, other inhibitory molecules, such as PD-1 and BTLA, containing the canonical ITIM as well as ITSM motifs were shown to recruit SHP-2 in a phosphorylation-dependent manner [26,27]. Yet, a direct role of SHP-2 in their negative signaling cascade has not been shown.…”
Section: Introductionmentioning
confidence: 99%